Clinical Trial Update: Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated adding mistletoe extract as a complementary treatment to carboplatin/gemcitabine in advanced non-small cell lung cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• Mistletoe extract (Iscador) (mistletoe extract)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED